骨密度测定对恶性肿瘤与骨质疏松的相关性评价  

Relative evaluation of malignant tumor and osteoporosis by bone densitometry detection

作　　者：邱慧敏[1] 蔡海东[2] 陆思绮[2] 王辉[1] 茅伟[1] 许青[1] 

机构地区：[1]同济大学附属第十人民医院肿瘤科,上海200072 [2]同济大学附属第十人民医院核医学科,上海200072

出　　处：《同济大学学报（医学版）》2008年第5期132-134,共3页Journal of Tongji University(Medical Science)

摘　　要：目的探讨恶性肿瘤与骨质疏松的关系。方法选择恶性肿瘤患者和非肿瘤患者各34例,采用美国Hologic公司生产的QDR45000W中轴双能X线骨密度仪测定骨密度。结果恶性肿瘤组骨质疏松发生率为61.76%(21/34),对照组骨质疏松发生率为29.41%(10/34),肿瘤组骨密度明显低于对照组(P<0.01)。骨转移组与非骨转移组骨密度无显著性差异(P>0.05)。结论恶性肿瘤骨质疏松的发生率较高可能与恶性肿瘤本身有一定的相关性。Objective To study the relationship between malignant tumors and osteoporosis. Methods The bone density was detected by Hologic QDR45000W Bone Densitometry in 34 patients with malignant tumor and 34 without tumor. Results The incidence of osteoporosis in patients with malignant tumor was 61.74% （21/34）, while that of the control group was 29.41% （10/34）. The value of bone density in patients with malignant tumor was significantly lower than that in patients without malignant tumor （ P 〈 0.01 ）. There was no statistic difference （ P 〉 0.05 ） between patients with and without bone metastasis. Conclusion The higher incidence of osteoporosis in cancer patients is probably related with the malignant tumor.

关 键 词：恶性肿瘤 骨质疏松 骨密度 

分 类 号：R73[医药卫生—肿瘤]